Press releases 2009

DSM Pharmaceutical Products today announced that it has made a manufacturing alliance with Galenix, Saint Jean D'Illac, France, where DSM will be the preferred commercial scale manufacturing partner for Galenix commercial products on a global basis.

DSM Pharmaceutical Products has announced that their Greenville, North Carolina facility has received the Potent Compound Safety Certification from SafeBridge® Consultants, Inc. headquartered in Mountain View, California.

DSM announced today that its proprietary XD® Technology boosts bioreactor productivity and titers of mammalian cell culture processes by 5-10 fold for the production of proteins and antibodies.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that it has entered into a multi-million dollar contract with Shire US Manufacturing Inc., a subsidiary of Shire plc., for the manufacture and supply of specialty pharmaceutical products to Shire.

DSM Biologics and Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) announced today that they have entered into an agreement with Bioceros B.V. of Utrecht, The Netherlands to join their Vendor Network. Under the terms of the agreement, Bioceros will be a pre-approved cell line generation partner for licensees of the PER.C6® cell line located in the European Union.

DSM Pharmaceutical Products today announced that they will join the Green Chemistry Institute® Pharmaceutical Roundtable (Roundtable) of the American Chemical Society (ACS) as an associate member.